Gram-negative pneumonia.
Unger JD, Rose HD, Unger GF.
Radiology. 1973 May;107(2):283-91. doi: 10.1148/107.2.283.
Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological study.
Dong N, Zeng Y, Wang Y, Liu C, Lu J, Cai C, Liu X, Chen Y, Wu Y, Fang Y, Fu Y, Hu Y, Zhou H, Cai J, Hu F, Wang S, Wang Y, Wu Y, Chen G, Shen Z, Chen S, Zhang R.
Lancet Microbe. 2022 Nov;3(11):e846-e856. doi: 10.1016/S2666-5247(22)00221-X. Epub 2022 Oct 3.
Proteus mirabilis and Klebsiella pneumoniae as pathogens capable of causing co-infections and exhibiting similarities in their virulence factors.
Palusiak A.
Front Cell Infect Microbiol. 2022 Oct 20;12:991657. doi: 10.3389/fcimb.2022.991657. eCollection 2022.
Hospital-acquired pneumonia.
McHenry MC, Alfidi RJ, Deodhar SD, Braun WE, Popowniak KL.
Med Clin North Am. 1974 May;58(3):565-80. doi: 10.1016/s0025-7125(16)32144-7.
BACTERIAL NUCLEOTIDASES.
KOHN J, REIS JL.
J Bacteriol. 1963 Oct;86(4):713-6. doi: 10.1128/jb.86.4.713-716.1963.
Pneumonia due to Proteus mirabilis treated with penicillin and streptomycin.
SNORF LD, SHEPANEK L, et al.
J Am Med Assoc. 1947 Sep 27;135(4):222. doi: 10.1001/jama.1947.62890040002006a.
Clinical features of Proteus mirabilis pneumonia.
Okimoto N, Hayashi T, Ishiga M, Nanba F, Kishimoto M, Yagi S, Kurihara T, Asaoka N, Tamada S.
J Infect Chemother. 2010 Oct;16(5):364-6. doi: 10.1007/s10156-010-0059-3. Epub 2010 May 26.
Proteus mirabilis pneumonia with giant pneumatocele.
Thapa BR, Kumar L, Mitra SK.
Indian J Pediatr. 1987 Jul-Aug;54(4):593-7. doi: 10.1007/BF02749061.
Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
Yayan J, Ghebremedhin B, Rasche K.
BMC Pharmacol Toxicol. 2016 Mar 23;17:10. doi: 10.1186/s40360-016-0056-y.
Infectious pneumonias: a review.
Tecson F, Louria DB.
J Fam Pract. 1977 Feb;4(2):201-9.
